A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.
第一作者:
Rafael,de la Torre
第一单位:
IMIM-Hospital del Mar Medical Research Institute, E-08003 Barcelona, Spain; CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), E-08003 Barcelona, Spain; University Pompeu Fabra (CEXS-UPF), E-08003 Barcelona, Spain. Electronic address: rtorre@imim.es.
作者:
主题词
成年人(Adult);动物(Animals);儿茶素(Catechin);认知障碍(Cognition Disorders);疾病模型, 动物(Disease Models, Animal);双盲法(Double-Blind Method);女(雌)性(Female);脆性X综合征(Fragile X Syndrome);人类(Humans);男(雄)性(Male);小鼠(Mice);小鼠, 基因敲除(Mice, Knockout);中年人(Middle Aged);神经保护药(Neuroprotective Agents);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1016/j.clnu.2019.02.028
PMID
30962103
发布时间
2021-08-13
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文